SMS Pharmaceuticals (BOM:532815) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 30, 2026)


BOM:532815 SMS Pharmaceuticals Ltd BOM:532815
71 GF Score
Price ₹380.45
GF Value ₹261.81
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is SMS Pharmaceuticals Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

SMS Pharmaceuticals's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:532815 vs LLY, JNJ, ABBV: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - General subindustry, SMS Pharmaceuticals's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SMS Pharmaceuticals Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, SMS Pharmaceuticals's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where SMS Pharmaceuticals's Margin of Safety % (DCF Earnings Based) falls into.


BOM:532815
71GF Score
SMS Pharmaceuticals Ltd BOM:532815
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SMS Pharmaceuticals (BOM:532815) Overvalued in 2026?

Based on GuruFocus' analysis, SMS Pharmaceuticals stock appears to be overvalued. The current stock price of ₹380.45 is trading 45.3% above its estimated GF Value™ of ₹261.81. GuruFocus considers SMS Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for BOM:532815:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹261.81 vs. price of ₹380.45 (45.3% above fair value)
  • GF Score™: 71/100 with 4 warning signs

No single metric tells the full story. See the BOM:532815 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SMS Pharmaceuticals Business Description

Other Exchanges SMSPHARMA:India
Address Road. No. 5, Plot No. 72, H.No. 8-2-334 / 3 & 4, Opposite SBI Executive Enclave, Banjara Hills, Hyderabad, TG, IND, 500034
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the business of manufacturing Active Pharma Ingredients and their intermediates. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, and other conditions.
71GF Score

Get the complete analysis for BOM:532815

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹380.45
Price
₹261.81
GF Value